Tradestie Institutional Equity Comparison Engine
BIOT vs HCIC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HCIC Overall Edge
HCIC Captures Institutional Edge (1โ0 Pillars ยท 3โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to HCIC (HCIC) driven by superior Momentum & Technical. Fundamentally, BIOT trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus HCIC at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BIOT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against HCIC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BIOT N/M vs HCIC N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
HCIC
1Y -98.8% vs +1.2% ยท 52W Pos 0% vs 80%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BIOT
US Equity
BIOT
Institutional Equity
$0.19
-1.1% 1D
Market Cap
N/A
1M Return
-17.65%
1Y Return
-98.79%
Forward P/E
N/M
Unified AI Score
52.7 / 100
HOLD
Tech 52.0
Fund 69.0
Flow 50.0
Mom 50.0
HCIC
US Equity
HCIC
Institutional Equity
$9.99
-0.2% 1D
Market Cap
N/A
1M Return
+0.1%
1Y Return
+1.22%
Forward P/E
N/M
Unified AI Score
57.6 / 100
HOLD
Tech 50.0
Fund 53.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BIOT -98.79%
HCIC +1.22%
Spread: +86.06 pp (HCIC Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BIOT TTM Op. Margin: N/A
HCIC TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BIOT vs HCIC. Trailing 12-month operating profitability (BIOT N/A vs HCIC N/A) and valuation multiples (BIOT N/M vs HCIC N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BIOT | HCIC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 0% ($0โ$50) | 80% ($10โ$10) | Stronger Trend | HCIC |
| Beta / 30D Volatility Risk Regime | 2.81ฮฒ ยท 101% Vol | 0.01ฮฒ ยท 1% Vol | Lower Realized Risk | HCIC |
| Unified Institutional Score Composite Signal | 52.7 / 100 (HOLD) | 57.6 / 100 (HOLD) | Higher Composite | HCIC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BIOT vs HCIC Buy Guide
BIOT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
HCIC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BIOT nor HCIC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.